Admin_Adham
Jump to Key Points The FDA has cleared Beta Bionics Inc.’s Mint, a new type of insulin patch pump.
The device features a “reusable and disposable architecture that does not require recharging.” It integrates with Dexcom G7, Dexcom G7 15 Day, and Abbott’s FreeStyle Libre 3 Plus continuous glucose monitors and with both iOS and Android smartphones. Commercial launch is expected in the first quarter of 2027 and will be available exclusively in the pharmacy channel.
The Mint is smaller than the Omnipod, the only other tubeless pump currently available, and is also wearable for 3 days with an additional 12-hour grace period. The Mint has a 200-unit reservoir and doesn’t require recharging. It is waterproof up to 5 feet deep for 60 minutes.
Since 2023, Beta Bionics has also manufactured the tubed pump-based iLet Bionic Pancreas automated insulin-delivery system (AID), which differs from other AID systems in its greater degree of automation.
- FDA cleared Beta Bionics Mint, a tubeless insulin patch pump.
- Reusable + disposable design; no recharging required.
- Integrates with Dexcom G7, G7 15 Day, FreeStyle Libre 3 Plus; iOS/Android compatible.
- Smaller than Omnipod; 3-day wear + 12-hour grace; 200-unit reservoir.
- 3D Intelligence algorithm pending; Mint 3D/iLet 3D planned if cleared.
Both the Mint and the iLet are expected to work with a “next-generation insulin dosing algorithm” called 3D Intelligence, for which Beta Bionics has applied for FDA clearance. If licensed, the two products will be called Mint 3D and iLet 3D, respectively.
The 3D Intelligence offers a choice of three algorithms:
- Original, as in the current iLet
- Optimized, which builds on the current algorithm by incorporating “learnings from the company’s real-world experience with iLet”
- Conservative, providing a “more measured response when correcting high glucose levels”
Miriam E. Tucker is a freelance journalist based in the Washington, DC, area. She is a regular contributor to Medscape, with other work appearing in the Washington Post, NPR’s Shots blog, and Diatribe. She is on X @MiriamETucker and BlueSky @miriametucker.bsky.social.
